Professor of Biomedical Engineering, Vice Provost for the Fourth Purpose and Strategic Impact
Samuel Sia develops technologies for point-of-care blood tests, wearable sensors, and implantable devices, both in an academic and industry setting.
He co-developed a point-of-care blood test for prostate cancer which is being commercialized and has garnered FDA approval, and is co-founder of Rover Diagnostics which is developing rapid and low-cost detection of DNA and RNA.
Sia’s research has garnered coverage from Nature, Science, JAMA, Washington Post, Science News, Popular Science, Chemical and Engineering News and has been featured on the BBC, NPR, and Voice of America. MIT Technology Review named him as one of the top’s world young innovators in 2010, and he is an inducted fellow of the American Institute for Medical and Biological Engineering.
Sia is the founder of Harlem Biospace, a biotech incubator facility in New York City (developed with the NYC mayor’s office) that has hosted over 50 biotech companies. He also currently co-directs the entrepreneurship initiative for Columbia University’s School of Engineering and Applied Sciences.
In 2022, Sia was appointed Vice Provost for Fourth Purpose and Strategic Impact, a new office within the Provost's Office to advance the University's mission on the Fourth Purpose and make positive impact on the world. In this role, Sia is building University infrastructure and partnerships to help Columbia leverage scholarly knowledge to benefit the public good. The office builds mechanisms for internal collaborations, dissolves institutional barriers to partnerships, and works with external partners to transform innovation to community and global impact.
Sia has a B.Sc. in Biochemistry from the University of Alberta and a Ph.D. in Biophysics (with a HHMI predoctoral fellowship) from Harvard University. He completed a postdoctoral fellowship in chemistry and chemical biology at Harvard University.
Listen to Prof. Sia describe his lab's point-of-care diagnostics research on NPR Science Friday.
Prof. Sia is the current chair of the NIH study section Instrumentation and Systems (ISD), until 2024.